Publications by authors named "Shiraz Halloush"

Claim this Profile
E
Economic evaluation of brivaracetam in the adjunctive treatment of patients with focal-onset seizure in Jordan.
Shiraz Halloush, Nimer S Alkhatib, Osamah M Alfayez, Omar S Alkhezi, Rawan Al Froukh

Medicine (Baltimore)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thionated levofloxacin derivative: Potential repurposing for cancer treatment and synergism with doxorubicin on doxorubicin-resistant lung cancer cells.
Hamza Abumansour, Osama H Abusara, Mohammad Abu-Sini, Wiam Khalil, Ali I M Ibrahim, Shiraz Halloush

PLoS One· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective.
Nimer S Alkhatib, Abdulaali R Almutairi, Majid Almadi, Shiraz Halloush, Yazed Sulaiman H Al-Ruthia

PLoS One· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic impact of tobacco smoking and secondhand smoke exposure in Jordan: estimating the direct and indirect costs.
Nimer S Alkhatib, Eman Massad, Omar Rashdan, Wendy Max, Shiraz Halloush

J Med Econ· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The status and preparation for the next decade of biosimilars in the Middle Eastern and North African region.
Nimer S Alkhatib, Shiraz Halloush, Ivo Abraham

Expert Opin Biol Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective.
Shiraz Halloush, Nimer S Alkhatib, Abdulaali R Almutairi, Mathias Calamia, Hala Halawah

Ann Pharmacother· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in Jordan.
Hala H Halawah, Nimer S Alkhatib, Abdulaali R Almutairi, Mohammad Saleh, Shiraz S Halloush

J Med Econ· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals.
Ahmad Alamer, Abdulaali R Almutairi, Shiraz Halloush, Ahmed Al-Jedai, Ahmed Alrashed

Saudi Pharm J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gaps in pharmaceutical care for patients with mental health issues: A cross-sectional study.
Amal Akour, Shiraz Halloush, Mohmmad B Nusair, Muna Barakat, Fatima Abdulla

Int J Clin Pharm· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of palonosetron and dexamethasone-based triple and quadruple regimens in preventing highly emetogenic chemotherapy-induced nausea and vomiting.
Shiraz Halloush, Abdullah A Alhifany, Nimer S Alkhatib, Abdel Qader Al Bawab, Batool Al-Qawasmeh

Curr Med Res Opin· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives of the community in the developing countries toward telemedicine and pharmaceutical care during the COVID-19 pandemic.
Ahmad R Alsayed, Shiraz Halloush, Luai Hasoun, Dalal Alnatour, Abdullah Al-Dulaimi

Pharm Pract (Granada)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Six Commercially Available Closed-System Drug-Transfer Devices Against NIOSH's 2015 Draft Vapor Protocol.
Shiraz Halloush, Ivan A Reveles, Jim Koeller

Hosp Pharm· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis